Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Ophtamed AB
AB
Active
Org 5590266564
Storgatan 41, 573 32
Tranås
General medical practice activities
·
NACE 8621
Est. 2015 · 10 years old
10 employees
Monitor
Share
Sweden
/
Companies
/
General medical practice activities
/
Ophtamed AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
39M
29M
19M
10M
0M
2020: 3M
3M
2020
2021: 12M (+300% vs 2020)
12M
+300%
2021
2022: 22M (+83% vs 2021)
22M
+83%
2022
2023: 23M (+5% vs 2022)
23M
+5%
2023
2024: 31M (+35% vs 2023)
31M
+35%
2024
EBITDA
SEK millions
9M
7M
4M
2M
0M
2020: 0M
0M
2020
2021: 2M
2M
2021
2022: 6M (+200% vs 2021)
6M
+200%
2022
2023: 6M (0% vs 2022)
6M
0%
2023
2024: 7M (+17% vs 2023)
7M
+17%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
31 336
23 128
22 479
11 779
2 961
Staff expenses
—
—
—
—
—
EBITDA
6 560
6 307
5 513
2 207
314
Depreciation & amort.
−692
−615
−403
−293
−197
EBIT
5 868
5 692
5 110
1 914
117
Net financials
320
19
−1
−5
−5
Profit before tax
4 456
4 352
3 831
1 526
84
Tax
−950
−907
−790
−327
−19
Net profit
3 506
3 445
3 041
1 199
65
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
11 033
9 746
9 171
3 476
1 421
Equity
3 813
3 907
4 412
1 371
172
Long-term debt
0
454
0
0
0
Short-term debt
2 191
2 087
2 820
1 444
971
Total debt
2 191
2 541
2 820
1 444
971
Financial ratios
5-year trend
EBITDA margin
20,9 %
This company
15,8 %
Market median
This company
Market median
32% above market
2020
2024
Equity ratio
34,6 %
This company
38,2 %
Market median
This company
Market median
9% below market
2020
2024
Return on equity
91,9 %
This company
18,4 %
Market median
This company
Market median
399% above market
2020
2024
Net profit margin
11,2 %
This company
8,1 %
Market median
This company
Market median
38% above market
2020
2024
Asset turnover
2,84×
This company
1,12×
Market median
This company
Market median
154% above market
2020
2024
Debt / equity
1,89×
This company
0,62×
Market median
This company
Market median
205% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
View
PDF
More on Ophtamed AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
